The estimated Net Worth of Yoav Zvi Waizer is at least 9.28 千$ dollars as of 4 December 2017. Yoav Waizer owns over 10,000 units of Microbot Medical Inc stock worth over 9,276$ and over the last 7 years Yoav sold MBOT stock worth over 0$.
Yoav has made over 1 trades of the Microbot Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Yoav bought 10,000 units of MBOT stock worth 11,000$ on 4 December 2017.
The largest trade Yoav's ever made was buying 10,000 units of Microbot Medical Inc stock on 4 December 2017 worth over 11,000$. On average, Yoav trades about 2,500 units every 0 days since 2017. As of 4 December 2017 Yoav still owns at least 10,000 units of Microbot Medical Inc stock.
You can see the complete history of Yoav Waizer stock trades at the bottom of the page.
Yoav's mailing address filed with the SEC is C/O MICROBOT MEDICAL INC., 25 RECREATION PARK DRIVE, UNIT 108, HINGHAM, MA, 02043.
Over the last 8 years, insiders at Microbot Medical Inc have traded over 5,894,432$ worth of Microbot Medical Inc stock and bought 10,000 units worth 11,000$ . The most active insiders traders include Yoseph Bornstein、Investment Management Ltd A...、Moshe Shoham. On average, Microbot Medical Inc executives and independent directors trade stock every 37 days with the average trade being worth of 46,188$. The most recent stock trade was executed by Yoseph Bornstein on 19 October 2020, trading 4,881 units of MBOT stock currently worth 38,755$.
microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. through its unique platforms, microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. microbot’s virob platform is an autonomous advancing micro robot (aamr), less then 1mm in diameter, which has the ability to advance (forward/bac
Microbot Medical Inc executives and other stock owners filed with the SEC include: